Characteristics of Patients with Meningococcal Disease Aged 18–24 Years by College Attendance in the United States From 2014 to 2016
| Characteristic . | All 18- to 24-y-Olds, N = 163 . | By College Student Status . | ||
|---|---|---|---|---|
| College Student, N = 83 . | Noncollege Student, N = 80 . | P . | ||
| N (%) . | N (%) . | N (%) . | ||
| Sex | 163 (100.0) | 83 (100.0) | 80 (100.0) | .05 |
| Male | 79 (48.5) | 34 (41.0) | 45 (56.2) | |
| Female | 84 (51.5) | 49 (59.0) | 35 (43.8) | |
| Age, y | 163 (100.0) | 83 (100.0) | 80 (100.0) | <.01 |
| 18 | 39 (23.9) | 21 (25.3) | 18 (22.5) | |
| 19 | 34 (20.9) | 29 (34.9) | 5 (6.3) | |
| 20 | 29 (17.8) | 17 (20.5) | 12 (15.0) | |
| 21 | 23 (14.1) | 12 (14.5) | 11 (13.8) | |
| 22 | 9 (5.5) | 1 (1.2) | 8 (10.0) | |
| 23 | 16 (9.8) | 0 (0.0) | 16 (20.0) | |
| 24 | 13 (8.0) | 3 (3.6) | 10 (12.5) | |
| Race | 135 (82.8) | 70 (84.3) | 65 (81.3) | .24 |
| White | 103 (76.3) | 57 (81.4) | 46 (70.8) | |
| African American | 25 (18.5) | 9 (12.9) | 16 (24.6) | |
| Other | 7 (5.2) | 4 (5.7) | 3 (4.6) | |
| Ethnicity | 134 (82.2) | 66 (79.5) | 68 (85.0) | .06 |
| Hispanic | 25 (18.7) | 8 (12.1) | 17 (25.0) | |
| Non-Hispanic | 109 (81.3) | 58 (87.9) | 51 (75.0) | |
| Serogroup | 151 (92.6) | 78 (94.0) | 73 (91.3) | <.01 |
| B | 88 (58.3) | 60 (76.9) | 28 (38.4) | |
| C | 19 (12.6) | 3 (3.9) | 16 (21.9) | |
| W | 5 (3.3) | 1 (1.3) | 4 (5.5) | |
| Y | 15 (9.9) | 6 (7.7) | 9 (12.3) | |
| NG and/or othera | 24 (15.9) | 8 (10.3) | 16 (21.9) | |
| MenACWY dose | 109 (66.9) | 61 (73.5) | 48 (60.0) | <.01 |
| ≥1 | 72 (66.1) | 53 (86.9) | 19 (39.6) | |
| 0 | 37 (33.9) | 8 (13.1) | 29 (60.4) | |
| MenB vaccine | 33 (20.2) | 19 (22.9) | 14 (17.5) | >.99 |
| ≥1 dose | 1 (3.0) | 1 (5.3) | 0 (0.0) | |
| 0 doses | 32 (97.0) | 18 (94.7) | 14 (100.0) | |
| Outcome | 153 (93.9) | 77 (92.8) | 76 (95.0) | .83 |
| Survived | 134 (87.6) | 67 (87.0) | 67 (88.2) | |
| Died | 19 (12.4) | 10 (13.0) | 9 (11.8) | |
| Characteristic . | All 18- to 24-y-Olds, N = 163 . | By College Student Status . | ||
|---|---|---|---|---|
| College Student, N = 83 . | Noncollege Student, N = 80 . | P . | ||
| N (%) . | N (%) . | N (%) . | ||
| Sex | 163 (100.0) | 83 (100.0) | 80 (100.0) | .05 |
| Male | 79 (48.5) | 34 (41.0) | 45 (56.2) | |
| Female | 84 (51.5) | 49 (59.0) | 35 (43.8) | |
| Age, y | 163 (100.0) | 83 (100.0) | 80 (100.0) | <.01 |
| 18 | 39 (23.9) | 21 (25.3) | 18 (22.5) | |
| 19 | 34 (20.9) | 29 (34.9) | 5 (6.3) | |
| 20 | 29 (17.8) | 17 (20.5) | 12 (15.0) | |
| 21 | 23 (14.1) | 12 (14.5) | 11 (13.8) | |
| 22 | 9 (5.5) | 1 (1.2) | 8 (10.0) | |
| 23 | 16 (9.8) | 0 (0.0) | 16 (20.0) | |
| 24 | 13 (8.0) | 3 (3.6) | 10 (12.5) | |
| Race | 135 (82.8) | 70 (84.3) | 65 (81.3) | .24 |
| White | 103 (76.3) | 57 (81.4) | 46 (70.8) | |
| African American | 25 (18.5) | 9 (12.9) | 16 (24.6) | |
| Other | 7 (5.2) | 4 (5.7) | 3 (4.6) | |
| Ethnicity | 134 (82.2) | 66 (79.5) | 68 (85.0) | .06 |
| Hispanic | 25 (18.7) | 8 (12.1) | 17 (25.0) | |
| Non-Hispanic | 109 (81.3) | 58 (87.9) | 51 (75.0) | |
| Serogroup | 151 (92.6) | 78 (94.0) | 73 (91.3) | <.01 |
| B | 88 (58.3) | 60 (76.9) | 28 (38.4) | |
| C | 19 (12.6) | 3 (3.9) | 16 (21.9) | |
| W | 5 (3.3) | 1 (1.3) | 4 (5.5) | |
| Y | 15 (9.9) | 6 (7.7) | 9 (12.3) | |
| NG and/or othera | 24 (15.9) | 8 (10.3) | 16 (21.9) | |
| MenACWY dose | 109 (66.9) | 61 (73.5) | 48 (60.0) | <.01 |
| ≥1 | 72 (66.1) | 53 (86.9) | 19 (39.6) | |
| 0 | 37 (33.9) | 8 (13.1) | 29 (60.4) | |
| MenB vaccine | 33 (20.2) | 19 (22.9) | 14 (17.5) | >.99 |
| ≥1 dose | 1 (3.0) | 1 (5.3) | 0 (0.0) | |
| 0 doses | 32 (97.0) | 18 (94.7) | 14 (100.0) | |
| Outcome | 153 (93.9) | 77 (92.8) | 76 (95.0) | .83 |
| Survived | 134 (87.6) | 67 (87.0) | 67 (88.2) | |
| Died | 19 (12.4) | 10 (13.0) | 9 (11.8) | |
NG, nongroupable; —, not applicable.
Includes 22 with nongroupable and 2 with other (not specified) serogroups.